Archives

by in
Entry Author Date Location
Vaxxas Entices Merck to Try Needle-Free Vaccine Technique 10/08/12 Boston
We Have To Do Better on TB, In King County and High-Burden Countries 09/24/12 Seattle
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
Life Sciences Discovery Fund Gets New Leader, A Familiar Face 07/03/12 Seattle
Building Bridges in a New Global Health Landscape 06/04/12 Seattle
IDRI, Aeras Team Up to Develop Tuberculosis Vaccine 05/09/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
Harvard-Born TremRx Pursues New Vaccine Technology 02/29/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine 12/09/11 Detroit
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation 10/31/11 Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech 10/27/11 New York
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme 10/26/11 National
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question 10/19/11 Seattle
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine 10/18/11 Boston
Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science 10/13/11 Seattle
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In 09/08/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way 08/31/11 San Francisco
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Page 2 of 9 « previous page · next page »